Download raw/aaer/2017/AAER-3848.txt from codewithdark/SEC-RPT-Panel: direct link, hf CLI and curl.
- Browser
- Download file 24.4 kB
-
https://huggingface.co/datasets/codewithdark/SEC-RPT-Panel/resolve/main/raw/aaer/2017/AAER-3848.txt
- Command line
-
hf download hf://datasets/codewithdark/SEC-RPT-Panel/raw/aaer/2017/AAER-3848.txt
-
curl -L -o AAER-3848.txt https://huggingface.co/datasets/codewithdark/SEC-RPT-Panel/resolve/main/raw/aaer/2017/AAER-3848.txt
24.4 kB
| UNITED STATES OF AMERICA | |
| Before the | |
| SECURITIES AND EXCHANGE COMMISSION | |
| SECURITIES EXCHANGE ACT OF 1934 | |
| Release No. 79820 / January 18, 2017 | |
| ACCOUNTING AND AUDITING ENFORCEMENT | |
| Release No. 3848 / January 18, 2017 | |
| ADMINISTRATIVE PROCEEDING | |
| File No. 3-17794 | |
| In the Matter of | |
| KENNETH MACK and BRYAN | |
| McMILLAN | |
| Respondents. | |
| ORDER INSTITUTING CEASE-AND- | |
| DESIST PROCEEDINGS PURSUANT TO | |
| SECTION 21C OF THE SECURITIES | |
| EXCHANGE ACT OF 1934, MAKING | |
| FINDINGS, AND IMPOSING CEASE-AND- | |
| DESIST ORDERS AND PENALTIES | |
| I. | |
| The Securities and Exchange Commission (“Commission”) deems it appropriate that | |
| cease-and-desist proceedings be, and hereby are, instituted pursuant to Section 21C of the | |
| Securities Exchange Act of 1934 (“Exchange Act”), against Kenneth Mack (“Mack”) and Bryan | |
| McMillan (“McMillan”) (collectively “Respondents”). | |
| II. | |
| In anticipation of the institution of these proceedings, Respondents have submitted Offers | |
| of Settlement (“Offers”), which the Commission has determined to accept. Solely for the | |
| purpose of these proceedings and any other proceedings brought by or on behalf of the | |
| Commission, or to which the Commission is a party, and without admitting or denying the | |
| findings herein, except as to the Commission’s jurisdiction over them and the subject matter of | |
| these proceedings, which are admitted, and except as provided in Section IV.E herein, | |
| Respondents consent to the entry of this Order Instituting Cease-and-Desist Proceedings | |
| Pursuant to Section 21C of the Securities Exchange Act of 1934, Making Findings, and Imposing | |
| Cease-and-Desist Orders and Penalties (“Order”), as set forth below. | |
| 2 | |
| III. | |
| On the basis of this Order and Respondents’ Offers, the Commission finds | |
| 1 that: | |
| SUMMARY | |
| This matter concerns the conduct of Kenneth Mack (“Mack”) and Bryan McMillan | |
| (“McMillan”) in connection with a financial restatement that occurred at Orthofix International, | |
| N.V. (“Orthofix”). During the relevant period, McMillan served as the President of Orthofix’s | |
| largest segment – its Spine Segment – and Mack reported to him as a Vice President of Global | |
| Sales and Development responsible for the international portion of Orthofix’s Spine Segment. | |
| During the relevant period, Orthofix had an unwritten policy requiring that any modifications | |
| made to contractual, payment, or other related terms with international distributors be approved | |
| by the Chief Financial Officer of Orthofix’s Spine Segment (“Spine CFO”) before any final | |
| agreement occurred. During the relevant period, however, Respondents agreed to terms on two | |
| transactions with one of Orthofix’s largest distributors without the Spine CFO’s approval. Mack | |
| additionally negotiated transactions with two other international distributors containing various | |
| concessions without the Spine CFO’s knowledge or approval. Moreover, in connection with a | |
| fiscal year 2012 audit conducted by Orthofix’s independent auditors, Mack provided an | |
| inaccurate representation. | |
| As a result of the foregoing conduct, Mack and McMillan violated Exchange Act Section | |
| 13(b)(5) and Rule 13b2-1 and were a cause of Orthofix’s violations of the reporting and books | |
| and records provisions of the federal securities laws. Mack additionally violated Exchange Act | |
| Rule 13b2-2(b) through his inaccurate representation to Orthofix’s independent auditors. | |
| RESPONDENTS | |
| Kenneth Mack, age 45, served as the Vice President of Global Sales and Development | |
| for the international portion of Orthofix’s Spine Segment from March 2011 until May 2013 and | |
| is no longer employed at Orthofix. | |
| Bryan McMillan, age 46, served as Orthofix’s Spine Segment President from November | |
| 2011 through November 2012 and is no longer employed at Orthofix. | |
| 1 The findings herein are made pursuant to Respondents’ Offer and are not binding on any other person or | |
| entity in this or any other proceeding. | |
| 3 | |
| FACTS | |
| A. Orthofix’s Business and Structure | |
| 1. Orthofix’s business was primarily divided into two Global Business Segments during the | |
| relevant period – Spine and Orthopedics. During the relevant period, Spine was | |
| Orthofix’s largest segment and contributed two-thirds of the company’s overall revenues. | |
| 2. Spine had several operating divisions during the relevant period including Orthofix | |
| Spinal Implants (“OSI”), which was responsible for international sales of spinal implants | |
| and related instruments. | |
| 3. Spine sold products through various methods, including selling its products to | |
| international distributors who then sold the products to hospitals and physicians. | |
| 4. As Spine Segment President, McMillan was in charge of Spine’s sales and overall | |
| management. McMillan had several sales persons who worked under him, including | |
| Mack. | |
| 5. As Spine’s Vice President of Global Sales and Development, Mack was in essence the | |
| relationship manager for a number of relationships that OSI had with certain international | |
| distributors. Mack had a sales team of approximately four employees who reported to | |
| him and had day-to-day responsibility for certain distributor relationships. | |
| B. Distributor Business and Revenue Recognition Practices | |
| 6. Orthofix entered into written agreements with distributors of its product. These | |
| distributor agreements provided, among other things, standard payment terms for | |
| purchase of products. These standard payment terms ranged typically from 90 to 180 | |
| days. | |
| 7. During the relevant period, Spine had an unwritten policy requiring that modifications to | |
| the terms in existing distributor agreements be approved by the Chief Financial Officer of | |
| the Spine Segment (“Spine CFO”). The Spine CFO reported directly to McMillan and | |
| indirectly to the Orthofix CFO who was a principal executive officer of the company. | |
| 8. The Spine CFO’s approval authority in this regard extended to all aspects of distributor | |
| agreement terms, including pricing, commissions, discounts, extensions of payment | |
| terms, payment plans, returns, and exchanges. | |
| 9. With limited exceptions, Orthofix recognized revenue during the relevant period based on | |
| the “sell-in” method, which provides for revenue recognition upon shipment of products | |
| to the distributor. | |
| 4 | |
| 10. ASC 605-10-25-1 provides that revenue may be recognized only when it is both realized | |
| or realizable and earned. Consistent with the authoritative literature, Orthofix’s financial | |
| statements disclosed four criteria as its revenue recognition policy. | |
| 11. The four criteria are: (i) persuasive evidence of an arrangement exists; (ii) delivery has | |
| occurred or services have been rendered; (iii) the seller’s price to the buyer is fixed and | |
| determinable; and (iv) collectability is reasonably assured. | |
| C. McMillan and Mack Imposed Pressure to Meet Internal Sales Targets | |
| 12. During the relevant period, Orthofix had a culture of aggressively setting internal sales | |
| targets and imposing pressure upon its sales personnel to meet those targets. For | |
| example, on October 22, 2011, McMillan emailed Mack and others concerning the need | |
| for OSI to meet its fourth quarter forecast of $6 million in revenue. McMillan wrote “if | |
| we fail at this endeavor then the company will be at risk and next year will be Hell on | |
| Earth for all of us.” | |
| 13. Less than one year later – and again reflecting the pressure imposed to meet revenue | |
| targets – Mack sent the following email on August 28, 2012 to his sales team with the | |
| subject line “September Gut:” | |
| I need your gut feeling on the revenue we can generate in September. We need $2 | |
| million in addition to what is on the portal . . .based on the feedback I have received I | |
| have gotten so far, we are off about $1.5 million. I know what people say they need, | |
| but as you know this is important. We need to ask everyone to purchase just a bit | |
| more . . .if I have to walk into [McMillan’s] office and tell him we are short again, | |
| that is going to be a major problem. | |
| 14. After receiving the above email, one of the sales persons who reported to Mack emailed a | |
| colleague separately and wrote: | |
| I was just speaking with [Mack] and had finance listened to us last year we wouldn’t | |
| be in this mess. We all predicted our markets could not sustain this growth but they | |
| got greedy. Found this budget brutal because here we are for another year just | |
| estimating the dollars. | |
| D. Mack and McMillan Negotiate Transactions and Term Amendments with Brazilian | |
| Distributor | |
| 15. OSI had several international distributors during the relevant period, but its largest | |
| distributor of product was located in Brazil (hereinafter “the Brazilian Distributor”). In | |
| fact, for eight of the nine quarters from Q1 2011 to Q1 2013, the Brazilian Distributor | |
| was the Company’s second largest customer on a revenue per quarter basis. | |
| 5 | |
| 16. Entering 2012, the Brazilian Distributor’s amounts payable to Orthofix was | |
| approximately $11 million. In March 2012, McMillan and Mack had discussions with | |
| the Brazilian Distributor to address this issue. The Brazilian Distributor agreed to pay | |
| approximately $4.2 million of the amounts payable by the end of FY 2012 but only if the | |
| company delivered certain products by the end of April 2012. Orthofix did not, however, | |
| deliver the products by the end of April 2012. | |
| 17. In late May 2012, the Brazilian Distributor President and McMillan had a face-to-face | |
| meeting. As reflected in June 2012 email communications among the Brazilian | |
| Distributor President, McMillan, Mack, and other employees, the Brazilian Distributor | |
| President and McMillan discussed two things at that meeting. | |
| 18. First – since Orthofix had not delivered the products that the Brazilian Distributor had | |
| insisted upon by the end of April 2012 – the Brazilian Distributor President informed | |
| McMillan (and later Mack through June 2012 emails memorializing those discussions) | |
| that it would only pay $1.6 million of its amounts payable in December 2012 and $2.6 | |
| million in February 2013. | |
| 19. Second, McMillan discussed a product launch plan with the Brazilian Distributor to | |
| purchase approximately $2.5 million of an FDA approved Orthofix product called | |
| Firebird. This product, however, had not yet been approved by ANVISA (the Brazilian | |
| equivalent of the U.S. Food and Drug Administration), and therefore, could not be | |
| shipped into Brazil until such approval was obtained by the Brazilian Distributor. | |
| Neither Mack nor McMillan knew exactly when ANVISA would grant approval. | |
| 20. As reflected by June 2012 emails between the Brazilian Distributor, Mack, and | |
| McMillan, the Brazilian Distributor agreed to place the Firebird order on the following | |
| conditions: (i) one year to pay for the product contingent on ANVISA approval and (ii) | |
| 210 days to pay on all subsequent product orders. | |
| 21. Mack and McMillan agreed to the payment plan proposal and the Firebird order terms | |
| without approval from the Spine CFO. | |
| 22. The Spine CFO learned of the Firebird transaction a few weeks after the Firebird product | |
| had already been shipped. In particular, on July 24, 2012 Mack forwarded the Spine | |
| CFO an email describing the transaction along with a series of emails containing prior | |
| discussions among him, McMillan, other employees, and the Brazilian Distributor’s | |
| President. | |
| 23. The Spine CFO replied to both McMillan and Mack “[Ken], can you please address how | |
| we ended up with a full year to pay for the June order. I have a hard time managing that | |
| with a lot of pressure to reduce our ballooning [Days Sales Outstanding].” Mack replied, | |
| “we accepted this due to the need for that size of an order.” | |
| 6 | |
| 24. Orthofix recognized over $2 million in revenue from this transaction immediately upon | |
| shipping the implants to the Brazilian Distributor’s U.S. based subsidiary located in | |
| Atlanta, Georgia. In particular, Orthofix’s recognition of revenue in this regard was | |
| improper because the Brazilian Distributor’s obligation to pay, and the payment terms | |
| themselves, were contingent upon ANVISA approval and, therefore, revenue recognition | |
| was inconsistent with Orthofix’s accounting policy because it did not meet the fixed or | |
| determinable criteria or the collectability criteria. | |
| 25. On December 1, 2012, Mack emailed the Brazilian Distributor’s President and the Spine | |
| CFO and wrote “I believe you have been speaking with [the Spine CFO] about the end of | |
| the year payment of $4 million. They are all extremely anxious about this. This has to | |
| happen as agreed.” By this time, McMillan had left the company. | |
| 26. The Brazilian Distributor’s President replied “No [the Spine CFO] did not communicate | |
| with me, certainly because it is quite clear this was agreed with [McMillan]. We will pay | |
| $1.6 million in December.” | |
| 27. Mack forwarded this email to the Spine CFO, writing “this is a disaster,” despite the fact | |
| that Mack had been informed in June 2012 that the Brazilian Distributor would only pay | |
| $1.6 million in December 2012 as a result of the failure to deliver certain products by | |
| April 30, 2012. | |
| 28. Ultimately, Orthofix filed its FY 2012 Form 10-K in March 2013 and did not, among | |
| other things, adequately assess the collectability of the significant receivables it had with | |
| the Brazilian Distributor. | |
| E. Mack Improperly Negotiates Transactions with Spanish and Mexican Distributors | |
| 29. In July 2012, Mack, without getting the approval of the Spine CFO, solicited a Spanish | |
| Distributor of Orthofix product to place an $810,000 order in which he offered the | |
| distributor certain concessions, which he characterized as the “deal of the century.” The | |
| concessions included extended payment terms on the order and the right to return | |
| $250,000 of excess distributor inventory that resulted from the order. The Spanish | |
| Distributor placed this order. | |
| 30. In September 2012, Mack, again without getting the approval of the Spine CFO, solicited | |
| a Mexican Distributor of Orthofix product to place a $300,000 order in which he offered | |
| the Distributor a number of concessions. The concessions included extended payment | |
| terms on the order, payment of $60,000 in taxes for the Distributor to the Mexican tax | |
| authorities, expansion of sales territory and reduction in sales quotas for the next year. | |
| The Mexican Distributor placed this order. | |
| 31. Orthofix recognized revenue from these transactions upon shipment of the products. This | |
| was improper because payment terms and timing were contingent upon certain extra- | |
| 7 | |
| contractual concessions and, therefore, revenue recognition was inconsistent with | |
| Orthofix’s accounting policy because it did not meet the fixed or determinable criteria or | |
| the collectability criteria. | |
| F. Mack Makes Inaccurate Representation to Auditors | |
| 32. Mack made an inaccurate representation to Orthofix’s independent auditors in connection | |
| with their audit of the fiscal year 2012 financial statements. | |
| 33. In particular, under the direction of the-then Spine President (who was a principal | |
| executive officer of the company), Mack provided a misleading written representation to | |
| the independent auditor that stated inaccurately that the sales for which Mack was | |
| responsible did not include side agreements outside the terms of the sales contracts, | |
| extended payment terms, rights of return, or concessions. | |
| G. Orthofix’s Restatement | |
| 34. Orthofix materially misstated several of its annual and quarterly filings and | |
| corresponding earnings releases, failed to make and keep books and records which, in | |
| reasonable detail, accurately and fairly reflected the transactions and dispositions of the | |
| assets of the issuer, and failed to devise and maintain a system of internal accounting | |
| controls sufficient to provide reasonable assurance that transactions are recorded as | |
| necessary to permit the preparation of financial statements in conformity with generally | |
| accepted accounting principles. | |
| 35. Accordingly – in late March 2014 – Orthofix restated its financial statements for the first | |
| quarter of fiscal year 2013, all quarterly and annual periods in fiscal years 2012 and 2011, | |
| and the annual period for fiscal year 2010 and acknowledged certain material weaknesses | |
| in its internal control over financial reporting. | |
| VIOLATIONS | |
| 36. Under Section 21C of the Exchange Act, the Commission may impose a cease-and-desist | |
| order upon any person who is violating, has violated, or is about to violate any provision | |
| of the Exchange Act and upon any person that is, was, or would be a cause of the | |
| violation, due to an act or omission the person knew or should have known would | |
| contribute to such violation. | |
| 37. Section 13(a) of the Exchange Act requires issuers to file such periodic and other reports | |
| as the Commission may prescribe and in conformity with such rules as the Commission | |
| may promulgate. Exchange Act Rules 13a-1, 13a-11, and 13a-13 require the filing of | |
| annual, current, and quarterly reports, respectively. In addition to the information | |
| expressly required to be included in such reports, Rule 12b-20 of the Exchange Act | |
| requires issuers to add such further material information, if any, as may be necessary to | |
| make the required statements, in the light of the circumstances under which they are | |
| 8 | |
| made not misleading. “The reporting provisions of the Exchange Act are clear and | |
| unequivocal, and they are satisfied only by the filing of complete, accurate, and timely | |
| reports.” SEC v. Savoy Industries, 587 F.2d 1149, 1165 (D.C. Cir. 1978) (citing SEC v. | |
| IMC Int’1, Inc., 384 F. Supp. 889, 893 (N.D. Tex. 1974)). A violation of the reporting | |
| provisions is established if a report is shown to contain materially false or misleading | |
| information. SEC v. Kalvex, Inc., 425 F. Supp. 310, 316 (S.D.N.Y. 1975). | |
| 38. Section 13(b)(2)(A) of the Exchange Act requires issuers to “make and keep books, | |
| records, and accounts, which, in reasonable detail, accurately and fairly reflect the | |
| transactions and dispositions of the assets of the issuer.” | |
| 39. Exchange Act Section 13(b)(5) prohibits any person from knowingly circumventing or | |
| knowingly failing to implement a system of internal accounting controls or knowingly | |
| falsifying any book, record, or account described in Exchange Act Section 13(b)(2). | |
| 40. Exchange Act Rule 13b2-1 prohibits any person from, directly or indirectly, falsifying or | |
| causing to be falsified, any book, record, or account subject to Exchange Act Section | |
| 13(b)(2)(A). | |
| 41. Exchange Act Rule 13b2-2(b) prohibits any officer or director of an issuer or any other | |
| person acting under the direction thereof from directly or indirectly taking any action to | |
| mislead an accountant engaged in the performance of an audit if that person knew or | |
| should have known that such action, if successful, could result in rendering the issuer’s | |
| financial statements materially misleading. | |
| 42. As a result of the conduct described above, Mack and McMillan violated Exchange Act | |
| Section 13(b)(5) and Rule 13b2-1 and were a cause of Orthofix’s violations of Exchange | |
| Act Sections 13(a) and 13(b)(2)(A) and Rules 12b-20, 13a-1, 13a-11, and 13a-13 | |
| thereunder. Mack additionally violated Exchange Act Rule 13b2-2(b). | |
| IV. | |
| In view of the foregoing, the Commission deems it appropriate to impose the sanctions | |
| agreed to in Respondents’ Offers. | |
| Accordingly, it is hereby ORDERED that: | |
| A. Pursuant to Section 21C of the Exchange Act, Respondents shall cease and desist | |
| from committing or causing any violations and any future violations of Exchange Act Sections | |
| 13(a), 13(b)(2)(A), 13(b)(5) and Rules 12b-20, 13a-1, 13a-11, 13a-13, and 13b2-1 thereunder. | |
| Respondent Mack shall further cease and desist from committing or causing any violations and | |
| any future violations of Exchange Act Rule 13b2-2(b). | |
| 9 | |
| B. Within 30 days of the entry of this order, Mack shall pay a civil money penalty of | |
| $40,000 and McMillan shall pay a civil money penalty of $25,000. If timely payment is not | |
| made, additional interest shall accrue pursuant to 31 U.S.C. § 3717. | |
| C. Payment must be made in one of the following three ways: | |
| (1) Respondent may transmit payment electronically to the Commission, which | |
| will provide detailed ACH transfer/Fedwire instructions upon request | |
| 2 | |
| ; | |
| (2) Respondent may make direct payment from a bank account via Pay.gov | |
| through the SEC website at http://www.sec.gov/about/offices/ofin.htm; or | |
| (3) Respondent may pay by certified check, bank cashier’s check, or United | |
| States postal money order, made payable to the Securities and Exchange | |
| Commission and hand-delivered or mailed to: | |
| Enterprise Services Center | |
| Accounts Receivable Branch | |
| HQ Bldg., Room 181, AMZ-341 | |
| 6500 South MacArthur Boulevard | |
| Oklahoma City, OK 73169 | |
| Payments by check or money order must be accompanied by a cover letter identifying the | |
| Respondent in these proceedings, and the file number of these proceedings; a copy of the cover | |
| letter and check or money order must be sent to Antonia Chion, Division of Enforcement, | |
| Securities and Exchange Commission, 100 F Street, NE, Washington, DC 20549-5720. | |
| D. Pursuant to Section 308(a) of the Sarbanes-Oxley Act of 2002, as amended, a Fair | |
| Fund is created for the penalties referenced in paragraph IV.B above. This Fair Fund may be added | |
| to or combined with the fair fund established in In the Matter of Orthofix International, N.V., (AP | |
| File No. 3-17791; Release No.10281, January 18, 2017) and/or may be added to or combined with | |
| fair funds established for the civil penalties paid by other Respondents for conduct arising in relation | |
| to the violative conduct at issue in this proceeding or the Orthofix proceeding, in order for the | |
| combined fair funds to be distributed to harmed investors affected by the same violative conduct. | |
| Regardless of whether any such Fair Fund distribution is made, amounts ordered to be paid as civil | |
| money penalties pursuant to this Order shall be treated as penalties paid to the government for all | |
| purposes, including all tax purposes. To preserve the deterrent effect of the civil penalty, | |
| Respondent agrees that in any Related Investor Action, it shall not argue that it is entitled to, nor | |
| shall it benefit by, offset or reduction of any award of compensatory damages by the amount of | |
| 2 | |
| The minimum threshold for transmission of payment electronically is $1,000,000. For amounts below the | |
| threshold, respondents must make payments pursuant to option (2) or (3) above. | |
| 10 | |
| any part of Respondent’s payment of a civil penalty in this action (“Penalty Offset”). If the court | |
| in any Related Investor Action grants such a Penalty Offset, Respondent agrees that it shall, | |
| within 30 days after entry of a final order granting the Penalty Offset, notify the Commission's | |
| counsel in this action and pay the amount of the Penalty Offset to the Securities and Exchange | |
| Commission. Such a payment shall not be deemed an additional civil penalty and shall not be | |
| deemed to change the amount of the civil penalty imposed in this proceeding. For purposes of | |
| this paragraph, a “Related Investor Action” means a private damages action brought against | |
| Respondent by or on behalf of one or more investors based on substantially the same facts as | |
| alleged in the Order instituted by the Commission in this proceeding. | |
| E. It is further ordered that, solely for purposes of exceptions to discharge set forth in | |
| Section 523 of the Bankruptcy Code, 11 U.S.C. §523, the findings in this Order are true and | |
| admitted by Respondents, and further, any debt for disgorgement, prejudgment interest, civil | |
| penalty or other amounts due by Respondent under this Order or any other judgment, order, | |
| consent order, decree or settlement agreement entered in connection with this proceeding, is a | |
| debt for the violation by Respondent of the federal securities laws or any regulation or order | |
| issued under such laws, as set forth in Section 523(a)(19) of the Bankruptcy Code, 11 U.S.C. | |
| §523(a)(19). | |
| By the Commission. | |
| Brent J. Fields | |
| Secretary | |
| DMS4415287v7 |